SCHEMBL29566767

SCHEMBL29566767

CCc1c(Cl)nc(NS(=O)(=O)c2cnn(C)c2)nc1Oc1cccc(N2CCN(C(C)=O)CC2)c1Cl

nearest known ligand 0.35

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HCRTR1 O43613 1/20 0.35
▸ JAK2 O60674 3/20 0.35
▸ JAK1 P23458 3/20 0.35
▸ TYK2 P29597 3/20 0.35
▸ JAK3 P52333 3/20 0.35
▸ PIK3CB P42338 1/20 0.35
▸ MTOR P42345 1/20 0.35
▸ PIK3CG P48736 1/20 0.35
▸ TIPARP Q7Z3E1 1/20 0.34
▸ HTR6 P50406 2/20 0.33
▸ EGFR P00533 2/20 0.33
▸ ALDH1A1 P00352 4/20 0.33
▸ NPSR1 Q6W5P4 2/20 0.33
▸ MAPT P10636 2/20 0.32
▸ TRIM24 O15164 1/20 0.32
▸ PKM P14618 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ HTR1A P08908 1/20 0.32
▸ DRD2 P14416 1/20 0.32
▸ DRD4 P21917 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24309320 1.00 HCRTR1 (0.35) HCRTR1JAK2JAK1TYK2JAK3
SCHEMBL29566556 0.91 HTR1A (0.41) HTR6ALDH1A1HTR1ADRD2DRD4
SCHEMBL24309483 0.91 HTR1A (0.41) HTR6ALDH1A1HTR1ADRD2DRD4
SCHEMBL29566946 0.89 ALDH1A1 (0.36) HCRTR1JAK2JAK1TYK2JAK3
SCHEMBL26808181 0.89 ALDH1A1 (0.36) HCRTR1JAK2JAK1TYK2JAK3
SCHEMBL26811536 0.87 ALK (0.33) HCRTR1JAK2JAK1TYK2JAK3
SCHEMBL29567367 0.83 HTR6 (0.35) HTR6EGFRALDH1A1HTR1ADRD2
SCHEMBL24310029 0.83 HTR6 (0.35) HTR6EGFRALDH1A1HTR1ADRD2
SCHEMBL24310061 0.82 HTR1A (0.38) HTR6EGFRALDH1A1HTR1ADRD2
SCHEMBL29566917 0.82 HTR1A (0.38) HTR6EGFRALDH1A1HTR1ADRD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4225748-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR Vertex Pharmaceuticals Incorporated (US) 2023-08-16 — — EP disclosed
WO-2022076627-A1 MODULATORS OF CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR VERTEX PHARMACEUTICALS INCORPORATED (US) 2022-04-14 — — WO disclosed
Send feedback